Fujian Aonong Biological Technology Group Incorporation Ltd

Aonong Bio released its 2026 interim report. The company's total operating revenue was 4.521 billion yuan, and net profit attributable to the parent company was negative 190 million yuan, swinging from profit to loss. This was a decrease of 551 million yuan compared with the same period last year, a year-on-year decline of 152.61 percent. Net cash flow from operating activities was negative 329 million yuan, a decrease of 12.5302 million yuan compared with the same period last year. The company's asset-liability ratio was 62.08 percent, gross margin was 1.67 percent, return on equity was negative 6.41 percent, and diluted earnings per share was negative 0.07 yuan. The number of shareholders was 84,500, and the top ten shareholders held 43.12 percent of the total share capital.

Aonong Bio disclosed its semi-annual report on August 30. In the first half of 2026, the company achieved operating revenue of 4.521 billion yuan, up 14.25 percent year-on-year, but net profit attributable to shareholders of the listed company recorded a loss of 190 million yuan, compared with a profit of 361 million yuan in the same period last year, swinging from profit to loss year-on-year. During the reporting period, the change in revenue was mainly due to an increase in feed sales volume and expansion of the food segment.

Aonong Bio announced that its hog sales volume in July 2026 was 142,000 head, down 0.44% year-on-year and down 27.57% from June. Over the same period, its hog inventory stood at 960,900 head, up 69.12% year-on-year, up 16.68% from the end of June, and up 29.27% from the end of December 2025.